It is a complex of peptide fractions received from parathyroid young animals. The dedicated peptides have a selective action on cells of parathyroid, they normalize metabolism and also improve their functional activity. In clinical studies was indentified the effectiveness of “Bonothyrk” for restoration of functional activity parathyroid in cases of impairment various genesis, including during hyperparathyroidism, including osteoporosis, deossification, urolithiasis, muscle weakness, and also hypocalcemia, numbness and muscle spasms.
- in osteoporosis
- during deossification and urolithiasis
- in muscle weakness, hyperplasia parathyroid
- at numbness and muscle spasms, caused by hypocalcemia
Form release: 20 capsules of 0,2 g
Recommendations for use: adults 1-2 capsules 1-2 times daily with meals.
Receiving duration: one month.
Content(per 1 capsule): peptide complex A-21 (peptide of parathyroids), microcrystalline cellulose (E460, the flowing agent), gelatin (encapsulating agent), sugar beet (binding filler), lactose (excipient-humectant), starch (stabilizer), tween-80 (emulsifier), titanium dioxide (E171, coloring agent for capsules).
Daily dose contains: (2 capsules), 20 mg of peptide complex A-21.